CHMP issues positive opinion for JASCAYD (nerandomilast), bringing a new IPF and PPF therapy closer to patients in the EU
Not intended for US and UK media*Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are life-threatening, progressive lung c
